Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants

NCT01982903 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2016-05-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether urinary connective tissue growth factor (uCTGF) can predict the onset of fibrosis in transplanted kidneys.

Conditions

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Dirk Kuypers, MD, PhD · Laboratory of Nephrology, University Hospitals Leuven

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-06-30
Completion
2019-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01982903 on ClinicalTrials.gov